3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
11
Active not recruiting
6
Terminated
5
Withdrawn
3
Completed
2
Not yet recruiting
1
No longer available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Cyclophosphamide
31
Rituximab
23
zanubrutinib
18
Vincristine
15
fludarabine
14
Prednisone
14
venetoclax
13
blinatumomab
12
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
Doxorubicin
12
obinutuzumab
10
Bendamustine Hydrochloride
10
Lenalidomide
9
Dexamethasone
8
polatuzumab vedotin
7
glofitamab
7
Methotrexate
7
Biopsy
7
Radiotherapy
6
Prednisolone
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
6
Cytarabine
6
pirtobrutinib
5
pegaspargase
5
Immunotherapy, Adoptive
5
tislelizumab
4
tafasitamab
4
selinexor
4
orelabrutinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
loncastuximab tesirine
×
Lymphoid
×
Clear all
NCT07197307
2025-09-29
CLEAR
Universität Münster
Phase 2
Not yet recruiting
120 enrolled